Eli Lilly gets USFDA nod for Cyramza to treat hepatocellular carcinoma Medical Dialogues Bureau14 May 2019 9:47 AM ISTThe USFDA has removed the boxed warning from the CYRAMZA labelling which highlighted warnings pertaining to haemorrhage, gastrointestinal perforation...
Lupin launches generic Levothyroxine Sodium tablets Farhat Nasim22 March 2019 11:30 AM ISTLupin's Levothyroxine Sodium tablet is the generic version of AbbVie Inc's Synthroid tablets, it added. New Delhi: Drug firm Lupin Friday said it has...
Under pressure in diabetes, Novo Nordisk steps up focus on obesity drugs Ruby Khatun Khatun24 Nov 2017 9:30 AM ISTDenmark: Danish drugmaker Novo Nordisk is stepping up its efforts to treat obesity, seeking to tap into a potentially huge market as prices for its...
Roche Perjeta regimen gets FDA priority review in breast cancer Ruby Khatun Khatun4 Oct 2017 9:20 AM ISTZURICH: The U.S. Food and Drug Administration (FDA) has granted a priority review for Roche's Perjeta in combination with Herceptin and chemotherapy...
Novartis posts a win, Roche a flop in skin cancer trials Ruby Khatun Khatun12 Sept 2017 12:30 PM ISTZURICH/MADRID: Swiss drugmaker Novartis notched a trial win for its drug cocktail against skin cancer on Monday, while a rival treatment from Roche...
After melanoma surgery, Bristols Opdivo offers new care standard Ruby Khatun Khatun12 Sept 2017 9:15 AM ISTMADRID: Bristol-Myers Squibb's immunotherapy drug Opdivo is a better and safer option than its older medicine Yervoy for treating melanoma patients...
Margin on revision knee surgery implants as high as 277 percent: NPPA Ruby Khatun Khatun10 Aug 2017 11:30 AM ISTNew Delhi: Drug price regulator NPPA said it has found average trade margins on various knee implants used in revision surgery to be as high as 277...
